Is maternal obesity associated with sustained inflammation in extremely low gestational age newborns?

Early Human Development

Volumn 89, Issue 12, 2013, Pages 949-955

  Van Der Burg, Jelske W ^a,b   Allred, Elizabeth N ^c   McElrath, Thomas F ^d   Fichorova, Raina N ^d   Kuban, Karl ^e   O'Shea, T Michael ^f   Dammann, Olaf ^a,c,g   Leviton, Alan ^c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c HARVARD UNIVERSITY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e BOSTON MEDICAL CENTER   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Inflammation; Maternal obesity; Prematurity

Indexed keywords

ARTICLE; BLOOD SAMPLING; EXTREMELY LOW BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL OBESITY; NEWBORN; SPONTANEOUS PLACENTAL DELIVERY; ADULT; BLOOD; BODY MASS; COMPLICATION; FETAL DISEASES; INFLAMMATION; METABOLISM; OBESITY; PATHOLOGY; PLACENTA; PREGNANCY; PREMATURITY; STATISTICAL MODEL;

PLASMA PROTEIN;

ADULT; BLOOD PROTEINS; BODY MASS INDEX; FEMALE; FETAL DISEASES; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INFLAMMATION; LOGISTIC MODELS; OBESITY; PLACENTA; PREGNANCY;

EID: 84887608712     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2013.09.014     Document Type: Article

References (58)

1. Cnattingius S., Lambe M. Trends in smoking and overweight during pregnancy: prevalence, risks of pregnancy complications, and adverse pregnancy outcomes. Semin Perinatol Aug 2002, 26(4):286-295.
2. Catalano P.M., Ehrenberg H.M. The short- and long-term implications of maternal obesity on the mother and her offspring. BJOG Oct 2006, 113(10):1126-1133.
3. Rowlands I., Graves N., de Jersey S., McIntyre H.D., Callaway L. Obesity in pregnancy: outcomes and economics. Semin Fetal Neonatal Med Apr 2010, 15(2):94-99.
4. Ye J., McGuinness O.P. Inflammation during obesity is not all bad: evidence from animal and human studies. Am J Physiol Endocrinol Metab Mar 1 2013, 304(5):E466-E477.
5. Chmelar J., Chung K.J., Chavakis T. The role of innate immune cells in obese adipose tissue inflammation and development of insulin resistance. Thromb Haemost Mar 5 2013, 109(3):399-406.
6. De Oliviera Leal V., Mafra D. Adipokines in obesity. Clin Chim Acta Apr 18 2013, 419:87-94.
7. Lee J. Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 diabetes. Arch Pharm Res Feb 2013, 36(2):208-222.
8. Okwan-Duodu D., Umpierrez G.E., Brawley O.W., Diaz R. Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages. Am J Cancer Res 2013, 3(1):21-33.
9. Tanti J.F., Ceppo F., Jager J., Berthou F. Implication of inflammatory signaling pathways in obesity-induced insulin resistance. Front Endocrinol (Lausanne) 2012, 3:181.
10. Tchernof A., Despres J.P. Pathophysiology of human visceral obesity: an update. Physiol Rev Jan 2013, 93(1):359-404.
11. Challier J.C., Basu S., Bintein T., Minium J., Hotmire K., Catalano P.M., et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta Mar 2008, 29(3):274-281.
12. Verhaeghe J., van Bree R., Lambin S., Caluwaerts S. Adipokine profile and C-reactive protein in pregnancy: effects of glucose challenge response versus body mass index. J Soc Gynecol Investig Jul 2005, 12(5):330-334.
13. Stewart F.M., Freeman D.J., Ramsay J.E., Greer I.A., Caslake M., Ferrell W.R. Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab Mar 2007, 92(3):969-975.
14. Madan J.C., Davis J.M., Craig W.Y., Collins M., Allan W., Quinn R., et al. Maternal obesity and markers of inflammation in pregnancy. Cytokine Jul 2009, 47(1):61-64.
15. Basu S., Haghiac M., Surace P., Challier J.C., Guerre-Millo M., Singh K., et al. Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring) Mar 2011, 19(3):476-482.
16. Schmatz M., Madan J., Marino T., Davis J. Maternal obesity: the interplay between inflammation, mother and fetus. J Perinatol Jul 2010, 30(7):441-446.
17. Ruager-Martin R., Hyde M.J., Modi N. Maternal obesity and infant outcomes. Early Hum Dev Nov 2010, 86(11):715-722.
18. Lawlor D.A., Smith G.D., O'Callaghan M., Alati R., Mamun A.A., Williams G.M., et al. Epidemiologic evidence for the fetal overnutrition hypothesis: findings from the mater-university study of pregnancy and its outcomes. Am J Epidemiol Feb 15 2007, 165(4):418-424.
19. Lieb W., Pencina M.J., Lanier K.J., Tofler G.H., Levy D., Fox C.S., et al. Association of parental obesity with concentrations of select systemic biomarkers in nonobese offspring: the Framingham Heart Study. Diabetes Jan 2009, 58(1):134-137.
20. Leibowitz K.L., Moore R.H., Ahima R.S., Stunkard A.J., Stallings V.A., Berkowitz R.I., et al. Maternal obesity associated with inflammation in their children. World J Pediatr Feb 2012, 8(1):76-79.
21. Bilbo S.D., Tsang V. Enduring consequences of maternal obesity for brain inflammation and behavior of offspring. FASEB J Jun 2010, 24(6):2104-2115.
22. Boney C.M., Verma A., Tucker R., Vohr B.R. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics Mar 2005, 115(3):e290-e296.
23. Basatemur E., Gardiner J., Williams C., Melhuish E., Barnes J., Sutcliffe A. Maternal prepregnancy BMI and child cognition: a longitudinal cohort study. Pediatrics Jan 2013, 131(1):56-63.
24. Van Lieshout R.J., Taylor V.H., Boyle M.H. Pre-pregnancy and pregnancy obesity and neurodevelopmental outcomes in offspring: a systematic review. Obes Rev May 2011, 12(5):e548-e559.
25. Brion M.J., Zeegers M., Jaddoe V., Verhulst F., Tiemeier H., Lawlor D.A., et al. Intrauterine effects of maternal prepregnancy overweight on child cognition and behavior in 2 cohorts. Pediatrics Jan 2011, 127(1):e202-e211.
26. Tanda R., Salsberry P.J., Reagan P.B., Fang M.Z. The impact of prepregnancy obesity on children's cognitive test scores. Matern Child Health J Feb 2013, 17(2):222-229.
27. Casas M., Chatzi L., Carsin A.E., Amiano P., Guxens M., Kogevinas M., et al. Maternal pre-pregnancy overweight and obesity, and child neuropsychological development: two Southern European birth cohort studies. Int J Epidemiol Apr 2013, 42(2):506-517.
28. Craig W.Y., Palomaki G.E., Neveux L.M., Haddow J.E. Maternal body mass index during pregnancy and offspring neurocognitive development. Obstet Med 2013, 6:20-25.
29. Leviton A., Kuban K., O'Shea T.M., Paneth N., Fichorova R., Allred E.N., et al. The relationship between early concentrations of 25 blood proteins and cerebral white matter injury in preterm newborns: the ELGAN study. J Pediatr Jun 2011, 158(6):897-903. [e1-5].
30. O'Shea T.M., Allred E.N., Kuban K.C., Dammann O., Paneth N., Fichorova R., et al. Elevated concentrations of inflammation-related proteins in postnatal blood predict severe developmental delay at 2years of age in extremely preterm infants. J Pediatr Mar 2012, 160(3):395-401. [e4].
31. Leviton A., Kuban K.C., Allred E.N., Fichorova R.N., O'Shea T.M., Paneth N. Early postnatal blood concentrations of inflammation-related proteins and microcephaly two years later in infants born before the 28th post-menstrual week. Early Hum Dev May 2011, 87(5):325-330.
32. O'Shea T.M., Allred E.N., Dammann O., Hirtz D., Kuban K.C., Paneth N., et al. The ELGAN study of the brain and related disorders in extremely low gestational age newborns. Early Hum Dev Nov 2009, 85(11):719-725.
33. NHI Classification of overweight and obesity by BMI, waist circumference, and associated disease risks. National Institute of Health [cited 2013 04-23-2013]; Available from. http://www.nhlbi.nih.gov/health/public/heart/obesity/lose_wt/bmi_dis.htm.
34. McElrath T.F., Hecht J.L., Dammann O., Boggess K., Onderdonk A., Markenson G., et al. Pregnancy disorders that lead to delivery before the 28th week of gestation: an epidemiologic approach to classification. Am J Epidemiol Aug 27 2008, 168(9):980-989.
35. McElrath T.F., Fichorova R.N., Allred E.N., Hecht J.L., Ismail M.A., Yuan H., et al. Blood protein profiles of infants born before 28weeks differ by pregnancy complication. Am J Obstet Gynecol May 2011, 204(5):e1-e12. [418].
36. Hecht J.L., Fichorova R.N., Tang V.F., Allred E.N., McElrath T.F., Leviton A. Relationship between neonatal blood protein concentrations and placenta histologic characteristics in extremely low GA newborns. Pediatr Res Jan 2011, 69(1):68-73.
37. Hecht J.L., Allred E.N., Kliman H.J., Zambrano E., Doss B.J., Husain A., et al. Histological characteristics of singleton placentas delivered before the 28th week of gestation. Pathology 2008 Jun, 40(4):372-376.
38. Yudkin P.L., Aboualfa M., Eyre J.A., Redman C.W., Wilkinson A.R. New birthweight and head circumference centiles for gestational ages 24 to 42weeks. Early Hum Dev 1987 Jan, 15(1):45-52.
39. Leviton A., Paneth N., Reuss M.L., Susser M., Allred E.N., Dammann O., et al. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Developmental Epidemiology Network Investigators. Pediatr Res Nov 1999, 46(5):566-575.
40. Fichorova R.N., Trifonova R.T., Gilbert R.O., Costello C.E., Hayes G.R., Lucas J.J., et al. Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells. Infect Immun Oct 2006, 74(10):5773-5779.
41. Fichorova R.N., Richardson-Harman N., Alfano M., Belec L., Carbonneil C., Chen S., et al. Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study. Anal Chem Jun 15 2008, 80(12):4741-4751.
42. Fichorova R.N., Onderdonk A.B., Yamamoto H., Delaney M.L., DuBois A.M., Allred E., et al. Maternal microbe-specific modulation of inflammatory response in extremely low-gestational-age newborns. MBio 2011, 2(1):e00280-e.
43. Leviton A., Fichorova R., Yamamoto Y., Allred E.N., Dammann O., Hecht J., et al. Inflammation-related proteins in the blood of extremely low gestational age newborns. The contribution of inflammation to the appearance of developmental regulation. Cytokine Jan 2011, 53(1):66-73.
44. Bose C., Laughon M., Allred E.N., Van Marter L.J., O'Shea T.M., Ehrenkranz R.A., et al. Blood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestation. Pediatr Res 2011, 69(4):347-353.
45. Dubin N., Pasternack B.S. Risk assessment for case-control subgroups by polychotomous logistic regression. Am J Epidemiol 1986 Jun, 123(6):1101-1117.
46. McElrath T., Allred E.N., Van Marter L., Fichorova R., Leviton A. Perinatal systemic inflammatory responses of growth-restricted preterm newborns. Acta Paediatr Oct 2013, 102(10):439-442.
47. Bluher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol Feb 2010, 21(1):38-43.
48. Primeau V., Coderre L., Karelis A.D., Brochu M., Lavoie M.E., Messier V., et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) Jul 2011, 35(7):971-981.
49. Calori G., Lattuada G., Piemonti L., Garancini M.P., Ragogna F., Villa M., et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care Jan 2011, 34(1):210-215.
50. Heraclides A., Jensen T.M., Rasmussen S.S., Eugen-Olsen J., Haugaard S.B., Borch-Johnsen K., et al. The pro-inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is associated with incident type 2 diabetes among overweight but not obese individuals with impaired glucose regulation: effect modification by smoking and body weight status. Diabetologia Jul 2013, 56(7):1542-1546.
51. Zarkesh-Esfahani H., Pockley G., Metcalfe R.A., Bidlingmaier M., Wu Z., Ajami A., et al. High-dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol Oct 15 2001, 167(8):4593-4599.
52. Dixit V.D., Schaffer E.M., Pyle R.S., Collins G.D., Sakthivel S.K., Palaniappan R., et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest Jul 2004, 114(1):57-66.
53. Busso N., So A., Chobaz-Peclat V., Morard C., Martinez-Soria E., Talabot-Ayer D., et al. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol Jan 15 2002, 168(2):875-882.
54. Mancuso P., Gottschalk A., Phare S.M., Peters-Golden M., Lukacs N.W., Huffnagle G.B. Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J Immunol Apr 15 2002, 168(8):4018-4024.
55. Ikejima S., Sasaki S., Sashinami H., Mori F., Ogawa Y., Nakamura T., et al. Impairment of host resistance to Listeria monocytogenes infection in liver of db/db and ob/ob mice. Diabetes Jan 2005, 54(1):182-189.
56. Ridker P.M., Pare G., Parker A., Zee R.Y., Danik J.S., Buring J.E., et al. Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet May 2008, 82(5):1185-1192.
57. Fichorova R.N., Onderdonk A.B., Yamamoto H., M.L.D, Dubois A.M., Allred E., et al. Microbe-specific modulation of inflammatory response in extremely low gestational age newborns. MBio 2011, 2(1):e00280-e.
58. Arnold C.C., Kramer M.S., Hobbs C.A., McLean F.H., Usher R.H. Very low birth weight: a problematic cohort for epidemiologic studies of very small or immature neonates. Am J Epidemiol Sep 15 1991, 134(6):604-613.